The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

HealthSouth Corp

NYSE: HLS
Last

(U.S.) $44.32

Today's change+0.27 +0.61%
Updated August 16 4:02 PM EDT. Delayed by at least 15 minutes.
 

HealthSouth Corp

NYSE: HLS
Last

(U.S.) $44.32

Today's change+0.27 +0.61%
Updated August 16 4:02 PM EDT. Delayed by at least 15 minutes.

HealthSouth Corp up (U.S.)$0.27

HealthSouth Corp closed up Wednesday by (U.S.)$0.27 or 0.61% to (U.S.)$44.32. Over the last five days, shares have gained 1.40% and 7.47% year to date. Shares have underperformed the S&P 500 by 5.27% during the last year.

Key company metrics

  • Open(U.S.) $44.08
  • Previous close(U.S.) $44.05
  • High(U.S.) $44.56
  • Low(U.S.) $44.08
  • Bid / Ask(U.S.) $39.90 / (U.S.) $0.00
  • YTD % change+7.47%
  • Volume621,627
  • Average volume (10-day)1,127,677
  • Average volume (1-month)1,000,830
  • Average volume (3-month)971,047
  • 52-week range(U.S.) $36.97 to (U.S.) $49.71
  • Beta0.61
  • Trailing P/E17.13×
  • P/E 1 year forward16.24×
  • Forward PEG1.89×
  • Indicated annual dividend(U.S.) $1.00
  • Dividend yield2.26%
  • Trailing EPS(U.S.) $2.59
Updated August 16 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.58%

Based on its net profit margin of 8.58%, HealthSouth Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue968958935912
Total other revenue--------
Total revenue968958935912
Gross profit931921900877
Total cost of revenue37373635
Total operating expense822796776753
Selling / general / administrative599585571545
Research & development--------
Depreciation / amortization46454444
Interest expense (income), net operating--------
Unusual expense (income)10003
Other operating expenses, total131129125126
Operating income145163160160
Interest income (expense), net non-operating-40-41-42-43
Gain (loss) on sale of assets--------
Other--------
Income before tax108124122120
Income after tax79858278
Income tax, total29404042
Net income63676562
Total adjustments to net income-----10
Net income before extra. items63676562
Minority interest-16-18-17-16
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items63676462
Inc. avail. to common incl. extra. items63676562
Diluted net income63676562
Dilution adjustment----1--
Diluted weighted average shares999910099
Diluted EPS excluding extraordinary itemsvalue per share0.630.680.650.62
Dividends per sharevalue per share0.240.240.240.24
Diluted normalized EPSvalue per share0.720.670.640.65